Description
Savi Pharmaceutical Joint Stock Company, founded in 2005, is a prominent player in the pharmaceutical industry, operating as a Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO). The company is engaged in the manufacturing and distribution of pharmaceuticals, delivering high-quality finished dosage forms and fostering innovation through strategic partnerships for technology transfer and licensing. Savi Pharmaceutical is dedicated to maintaining high standards, evidenced by its certifications in Japanese GMP and EU-GMP.
Services include:
– Contract Development and Manufacturing (CDMO)
– Finished Dosage Forms
– Toll/Contract Manufacturing
– Licensing in
– Technology Transfer
Savi Pharmaceutical Joint Stock Company continues to innovate and expand its operations, particularly in international markets, and is committed to excellence in the pharmaceutical sector. For more information, visit savipharm.vn.
Contact Information
Related Listings

CDMO Live Europe 2026
Experience the future of external manufacturing at CDMO Live, Rotterdam.
19-21st May 2026

External Manufacturing Leaders Rotterdam 2026
Exclusive event for senior external manufacturing leaders. 26th May 2026 at CDMO Live











